PLx Pharma (FRA:1D5A) Other Operating Expense : €-0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is PLx Pharma Other Operating Expense?

PLx Pharma's Other Operating Expense for the three months ended in Sep. 2022 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 was €-0.00 Mil.

PLx Pharma's quarterly Other Operating Expense increased from Mar. 2022 (€-0.00 Mil) to Jun. 2022 (€0.00 Mil) but then declined from Jun. 2022 (€0.00 Mil) to Sep. 2022 (€-0.00 Mil).

PLx Pharma's annual Other Operating Expense declined from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.00 Mil) and declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil).

PLx Pharma Other Operating Expense Historical Data

The historical data trend for PLx Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PLx Pharma Other Operating Expense Chart

PLx Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Operating Expense

Get a 7-Day Free Trial

PLx Pharma Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

PLx Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

PLx Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of PLx Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PLx Pharma (FRA:1D5A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PLx Pharma Inc (FRA:1D5A) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 The Green, Suite 11895, Dover, DE, USA, 19901

Website

https://www.plxpharma.com

PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.

PLx Pharma (FRA:1D5A) Headlines

No Headlines